An Alzheimer's biomarker blood test during middle age may help doctors detect very early signs of cognitive decline to help people better target modifiable risk factors, a new study indicates.

A team has identified an experimental molecule capable of "reprogramming" the brain's immune cells to restore part of their ...

In the early stages of Alzheimer's disease, the NHS says there are often signs to look out for - and these early dementia ...

A fragile cleanup system sitting on the surface of brain cells may help explain one of Alzheimer’s disease’s oldest mysteries ...

Blood test could detect signs of Alzheimer’s ‘decades before symptoms’ – study - The findings show that Alzheimer’s may be present in midlife and already linked to cognitive differences, researchers ...

Almost 50 more genes have been flagged as being linked to Alzheimer’s, along with changes in activity in crucial cells that ...

Dosing of adults with early Alzheimer’s disease in clinical trial expected H2 2026 -- Comprehensive preclinical program ...

The Lancet World Report examines why regulators in the US, UK, and Europe have reached different decisions on new ...

The retraction came from Neurobiology of Aging, which removed a 2011 paper claiming to show that a version of a protein called amyloid-β was responsible for memory loss in Alzheimer’s disease. On its ...

Two new tool compounds may help scientists study TAOK proteins linked to Alzheimer’s disease and other neurological disorders. Alzheimer’s disease is the leading cause of dementia and affects more ...

Alzheimer's blood test can spot protein linked with disease ...

The Maine Chapter of the Alzheimer's Association is advocating at both the state and national level to mandate insurance ...